{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:52:15Z","timestamp":1791471135340,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013945","name":"Institut de Recherches Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jhepr.2022.100651","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T12:05:50Z","timestamp":1671192350000},"page":"100651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-089X","authenticated-orcid":false,"given":"Klaus","family":"Seedorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-4295","authenticated-orcid":false,"given":"Csaba","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8067-4766","authenticated-orcid":false,"given":"Cedric","family":"Vinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent-Michel","family":"Vuillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpad","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Creusot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Broux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Geant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-7431","authenticated-orcid":false,"given":"Adel","family":"Hammoutene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mahieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Martiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-2946","authenticated-orcid":false,"given":"Fabien","family":"Melchiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9433-6872","authenticated-orcid":false,"given":"Miklos","family":"Nyerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-9724","authenticated-orcid":false,"given":"Philippe","family":"Delerive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100651_bib1","first-page":"1","article-title":"Nonalcoholic fatty liver disease","author":"Brunt","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jhepr.2022.100651_bib2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2022.100651_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100651_bib5","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2022.100651_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100651_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstr\u00f6m","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2022.100651_bib8","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b01701","article-title":"The race to bash NASH: emerging targets and drug development in a complex liver disease","author":"Romero","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhepr.2022.100651_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib11","first-page":"1","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.jhepr.2022.100651_bib12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100651_bib13","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/jn\/136.12.3022","article-title":"Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome","volume":"136","author":"Palmieri","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.jhepr.2022.100651_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1369\/0022155420946402","article-title":"4-HNE immunohistochemistry and image analysis for detection of lipid peroxidation in human liver samples using vitamin E treatment in NAFLD as a proof of concept","volume":"68","author":"Podszun","year":"2020","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jhepr.2022.100651_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jhepr.2022.100651_bib17","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2022.100651_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2022.100651_bib19","first-page":"52","article-title":"Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship","author":"Karkucinska-Wieckowska","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhepr.2022.100651_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jhepr.2022.100651_bib21","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100651_bib22","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1128\/MCB.00753-07","article-title":"Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response","volume":"27","author":"Tong","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100651_bib23","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","article-title":"Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100651_bib24","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100651_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/BJ20090471","article-title":"Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1","volume":"422","author":"Eggler","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.jhepr.2022.100651_bib26","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1073\/pnas.0307301101","article-title":"Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers","volume":"101","author":"Wakabayashi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100651_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2022.100651_bib28","doi-asserted-by":"crossref","first-page":"16490","DOI":"10.1074\/jbc.272.26.16490","article-title":"hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2","volume":"272","author":"Marini","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100651_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jhepr.2022.100651_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhepr.2022.100651_bib31","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.3748\/wjg.v20.i36.13079","article-title":"Role of Nrf2 in chronic liver disease","volume":"20","author":"Tang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100651_bib32","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/MCB.00677-14","volume":"34","author":"Meakin","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100651_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","article-title":"Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis","volume":"48","author":"Chowdhry","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhepr.2022.100651_bib34","first-page":"298","article-title":"Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice","author":"Sugimoto","year":"2010","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2022.100651_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00535-012-0552-9","article-title":"Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis","volume":"47","author":"Okada","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100651_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.107.135822","article-title":"NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet","volume":"325","author":"Tanaka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhepr.2022.100651_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-related factor 2)","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib38","first-page":"34","article-title":"Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis","volume":"2020","author":"Reisman","year":"2020","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jhepr.2022.100651_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9709","article-title":"Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance","volume":"12","author":"Azzimato","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2022.100651_bib40","first-page":"9","article-title":"The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity","author":"Bricambert","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100651_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022862","article-title":"Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR","volume":"6","author":"Yore","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100651_bib42","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2022.100651_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cardfail.2014.10.001","article-title":"Risk factors for heart failure in patients with type 2 diabetes mellitus\u00a0and stage 4 chronic kidney disease treated with bardoxolone methyl","volume":"20","author":"Chin","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhepr.2022.100651_bib44","doi-asserted-by":"crossref","first-page":"54750","DOI":"10.1074\/jbc.M410073200","article-title":"Crystal structure of the Kelch domain of human Keap1","volume":"279","author":"Li","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100651_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ddtec.2017.10.001","article-title":"The Keap1\u2013Nrf2 protein\u2013protein interaction: a suitable target for small molecules","volume":"24","author":"Schmoll","year":"2017","journal-title":"Drug Discov Today Tech"},{"key":"10.1016\/j.jhepr.2022.100651_bib46","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhepr.2022.100651_bib47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","article-title":"Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy","volume":"8","author":"Kristiansen","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib48","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100651_bib49","article-title":"Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression","volume":"17","author":"Morel","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100651_bib50","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1021\/acs.jmedchem.9b00723","article-title":"A comparative assessment study of known small-molecule Keap1-Nrf2 protein-protein interaction inhibitors: chemical synthesis, binding properties, and cellular activity","volume":"62","author":"Tran","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhepr.2022.100651_bib51","doi-asserted-by":"crossref","first-page":"126852","DOI":"10.1016\/j.bmcl.2019.126852","article-title":"Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators","volume":"30","author":"Ma","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jhepr.2022.100651_bib52","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4155\/fmc.12.93","article-title":"Macrocycles in new drug discovery","volume":"4","author":"Mallinson","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jhepr.2022.100651_bib53","article-title":"Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes","volume":"13","author":"Wen Wong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100651_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100651_bib55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","article-title":"Preclinical models of non-alcoholic fatty liver disease","volume":"68","author":"Santhekadur","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib56","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100651_bib57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbt.20177","article-title":"Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis","volume":"21","author":"Lickteig","year":"2007","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jhepr.2022.100651_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-020-01356-2","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100651_bib60","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100651_bib61","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jhep.2010.09.020","article-title":"Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver","volume":"54","author":"Iacobini","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.abb.2015.11.040","article-title":"Keap1\/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet","volume":"591","author":"Slocum","year":"2016","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jhepr.2022.100651_bib63","first-page":"23","article-title":"Downregulation of Keap1 confers features of a fasted metabolic state","volume":"2020","author":"Knatko","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.jhepr.2022.100651_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103335","article-title":"Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling","volume":"24","author":"Wang","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.jhepr.2022.100651_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201044","article-title":"Nrf2 protects stellate cells from Smad-dependent cell activation","volume":"13","author":"Prestigiacomo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100651_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/biology9110395","article-title":"Emerging roles of liver sinusoidal endothelial cells in nonalcoholic steatohepatitis","volume":"9","author":"Furuta","year":"2020","journal-title":"Biol"},{"key":"10.1016\/j.jhepr.2022.100651_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07859-7","article-title":"Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway","volume":"10","author":"Singh","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100651_bib68","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.freeradbiomed.2019.01.016","article-title":"Redox regulation by NRF2 in aging and disease","volume":"134","author":"Schmidlin","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhepr.2022.100651_bib70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/carcin\/bgp231","article-title":"Nrf2: friend or foe for chemoprevention?","volume":"31","author":"Kensler","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhepr.2022.100651_bib71","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2022.100651_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2005.10.185","article-title":"Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity","volume":"339","author":"Okawa","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2022.100651_bib73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100651_bib74","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jhep.2020.01.023","article-title":"NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly","volume":"72","author":"He","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2022.100651_bib75","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.26964","article-title":"Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis","volume":"60","author":"K\u00f6hler","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100651_bib76","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/hep.31859","article-title":"Pharmacological activation of Nrf2 enhances functional liver regeneration","volume":"74","author":"Chan","year":"2021","journal-title":"Hepatology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922002233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922002233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:31:29Z","timestamp":1762900289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922002233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2589555922002233"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100651","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100651"}}